Clinical Trials
2 trialsNCT07199010 2025-09-30
Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression
Innovent Biologics (Suzhou) Co. Ltd.
Not yet recruiting
NCT07008287 2025-07-22
Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases
Innovent Biologics (Suzhou) Co. Ltd.
Recruiting